Upregulated FKBP1A Suppresses Glioblastoma Cell Growth via Apoptosis Pathway

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Glioblastoma (GBM) is a lethal brain tumor with urgent need for novel therapeutic targets.
• The gene FKBP1A is implicated in tumor progression, but its specific role and mechanism in GBM remain unclear.

Purpose of the Study:

• To elucidate the role of FKBP1A in glioblastoma.
• To identify the molecular mechanisms underlying FKBP1A's function in GBM.

Main Methods:

• Weighted gene co-expression network analysis (WGCNA) and differential gene expression analysis using TCGA and GTEx data.
• Cell viability assays (CCK-8) on U87MG and t98g GBM cell lines.
• Bioinformatic analysis to identify key signaling pathways, followed by flow cytometry and Western blot validation.

Main Results:

• FKBP1A was identified as a hub gene in glioblastoma.
• Upregulated FKBP1A protein expression was shown to induce GBM cell death.
• The apoptosis and mTOR signaling pathways were identified as key mediators of FKBP1A's function.
• Validation confirmed that increased FKBP1A inhibits GBM growth through the apoptosis pathway.

Conclusions:

• FKBP1A plays a significant role in glioblastoma progression and cell death.
• Targeting FKBP1A, particularly through the apoptosis pathway, represents a promising therapeutic strategy for glioblastoma.
• These findings provide a foundation for developing novel treatments for this aggressive brain cancer.